Habib Sugar Mills Limited (PSX:HABSM)

Verve Therapeutics Ratios and Metrics

Market cap in millions PKR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	10,909	8,882	5,552	4,743	4,440	5,330
Market Cap Growth	15.13%	59.99%	17.05%	6.82%	-16.69%	22.10%
Enterprise Value	6,128	6,565	5,449	5,283	2,907	2,067
Last Close Price	80.81	60.88	31.39	24.21	20.63	22.77
PE Ratio	9.89	4.53	2.18	3.68	4.49	7.54
PS Ratio	0.53	0.43	0.28	0.37	0.45	0.53
PB Ratio	0.70	0.67	0.49	0.50	0.48	0.62
P/TBV Ratio	0.70	0.67	0.49	0.50	0.48	0.62
P/FCF Ratio	6.38	622.01	1.78	-	-	2.56
P/OCF Ratio	5.86	190.84	1.70	-	19.50	2.29
EV/Sales Ratio	0.30	0.32	0.27	0.41	0.29	0.20
EV/EBITDA Ratio	3.53	3.72	1.66	2.96	2.61	2.86
EV/EBIT Ratio	3.99	4.21	1.78	3.41	3.31	4.29
EV/FCF Ratio	3.58	459.75	1.74	-	-	0.99
Debt / Equity Ratio	0.05	0.07	0.10	0.00	0.00	0.00
Debt / EBITDA Ratio	0.65	0.52	0.35	0.01	0.01	0.03
Debt / FCF Ratio	0.45	64.82	0.37	-	-	0.01
Asset Turnover	0.94	1.09	1.28	1.02	0.86	0.93
Inventory Turnover	2.16	3.60	3.34	2.93	5.44	5.90
Quick Ratio	1.02	1.20	1.45	0.94	1.81	1.84
Current Ratio	2.28	2.21	2.20	2.34	2.71	2.53
Return on Equity (ROE)	7.67%	16.01%	24.40%	13.73%	11.07%	8.48%
Return on Assets (ROA)	2.81%	5.17%	12.24%	7.65%	4.78%	2.76%
Return on Capital (ROIC)	3.98%	7.34%	17.37%	10.31%	6.13%	3.61%
Return on Capital Employed (ROCE)	6.10%	11.60%	26.50%	16.00%	9.30%	5.50%
Earnings Yield	10.12%	22.07%	45.78%	27.19%	22.29%	13.27%
FCF Yield	15.68%	0.16%	56.27%	-11.51%	-0.59%	39.12%
Dividend Yield	7.42%	9.86%	19.12%	14.46%	14.54%	12.08%
Payout Ratio	59.22%	42.00%	17.11%	34.31%	40.57%	57.64%
Buyback Yield / Dilution	2.70%	10.00%	-	-	-	-
Total Shareholder Return	10.34%	19.86%	19.12%	14.46%	14.54%	12.08%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.